Research and Markets (http://www.researchandmarkets.com/research/grhgnh/implantable_drug) has announced the addition of the "2014 Report on the International Implantable Drug Delivery Devices Market - Trends and Forecasts to 2018" report to their offering.

Implantable drug delivery devices are drug eluting devices implanted at targeted sites for therapeutic applications. The global implantable drug delivery devices market was valued at USD 11.6 billion in 2011 and is expected to grow at a CAGR of 8.8% from 2012 to 2018 to reach an estimated value of USD 21.1 billion in 2018. The Asian implantable drug delivery devices market held a market share of over 15% in 2011 and will register the fastest CAGR during 2012 to 2018 owing to economic development in emerging economies such as India and China.

In terms of market leaders for individual product segments, Medtronic led the market in the global implantable infusion pumps market in 2011; however, its market share is expected to plummet by 2018 due to the Class I product recall of SynchroMed II in 2012. On the other hand, Boston Scientific Corporation dominated the coronary drug eluting stents market in 2011. Furthermore, Allergan Inc. will dominate the global intraocular drug delivery market in the coming years, owing to the growing popularity of its biodegradable implant - Ozurdex.

Implantable drug delivery devices gain precedence over other drug delivery devices due to the fact that these devices are implanted at the targeted site and deliver unaltered concentrations of drugs at regular intervals.

Key Topics Covered:

1 Preface

2 Executive Summary

3 Market Overview

4 Implantable Drug Delivery Devices Market, By Product Types

5 Global Implantable Drug Delivery Devices Market, By Technology

6 Global Implantable Drug Delivery Devices Market, By Applications

7 Implantable Drug Delivery Devices Market By Geography

8 Recommendations

9 Competitive Landscape

10 Company Profiles

Companies Mentioned:

  • Abbott Laboratories
  • Allergan, Inc.
  • Bausch & Lomb Inc.
  • Bayer Healthcare
  • Boston Scientific Corporation
  • Medtronic Inc.
  • Merck
  • Nucletron
  • Psivida Corp.

For more information visit http://www.researchandmarkets.com/research/grhgnh/implantable_drug

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals, Drug Delivery